Impact of Peripheral Vascular Stiffness Assessment on Risk Prediction in Patients With Myocardial Infarction

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

2000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-02-17

Study Completion Date

2030-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Risk assessment after myocardial infarction is critical in daily practice and evolution toward heart failure especially diastolic heart failure remains a key issue. All consecutive patients with myocardial infarction (either STEMI or NSTEMI but excluding type 2 MI) presenting at university hospital of Lille within 48 hours after symptom onset will be recruited in the RIGID-MI registry. The RIGID-MI study proposes to deeply evaluate at 1 month after MI: peripheral vascular disease, vascular stiffness, ventriculo-arterial coupling and other usual risk factors. The main objective is to identify clinical, biological and imaging parameters associated with poor prognosis, especially evolution toward diastolic heart failure, recurrence of MI, and bleeding.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Arterial Stiffening as a Predictor for Diastolic Cardiac Dysfunction and HFpEF

NCT06208007

Heart Failure With Preserved Ejection Fraction Cardiovascular Morbidity

RECRUITING

Non-invasive Evaluation of Myocardial Stiffness by Elastography

NCT02537041

Diastolic Heart Failure

COMPLETED NA

The Assessment of Large and Small Artery Elasticity for the Early Detection of Cardiovascular Disease

NCT02863211

Cardiovascular Diseases Vascular Stiffness

UNKNOWN

Evaluation of Infarct Size With 3D Rotational Angiography

NCT02857985

Myocardial Infarction

COMPLETED NA

Retrospective Study to Estimate the Current Status of Patients With Non-Obstructive coroNary Artery Disease

NCT03584321

Non-Obstructive Coronary Artery Disease

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Myocardial Infarction Vascular Stiffness Heart Failure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients with myocardial

Imaging evaluation for vascular assessment

Intervention Type OTHER

At 1month after MI, Blood sample for total blood, plasma and PBMC collection, ECG, 3D-trans thoracic echocardiography for ventriculo-arterial coupling assessment, Vascular doppler for peripheral artery disease assessment, Arterial stiffness evaluation, Bilateral transcranial doppler for HITS evaluation

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Imaging evaluation for vascular assessment

At 1month after MI, Blood sample for total blood, plasma and PBMC collection, ECG, 3D-trans thoracic echocardiography for ventriculo-arterial coupling assessment, Vascular doppler for peripheral artery disease assessment, Arterial stiffness evaluation, Bilateral transcranial doppler for HITS evaluation

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Signed informed consent
* Affiliated to national health insurance (French social security number)
* Presenting with MI within 48 hours of symptom onset

Exclusion Criteria

* Patient under curatorship
* Type 2 MI
* Presenting with MI after 48 hours of symptom onset
* Pregnancy or lactating
* Refuse to participate
* No national health insurance (No French social security number)

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No